Literature DB >> 2346781

Gova/b alloantigen system on human platelets.

J G Kelton1, J W Smith, P Horsewood, J R Humbert, C P Hayward, T E Warkentin.   

Abstract

In this report we describe a platelet alloantigen system that is carried on a novel platelet protein of 175 Kd. Antisera against the two alleles (Gova/Govb) were found in two patients who had received large numbers of platelet transfusions. The anti-Gov alloantibodies could not be detected using a whole platelet solid phase enzyme immunoassay, or by a platelet glycoprotein capture enzyme immunoassay using monoclonal antibodies against glycoproteins Ib/IX, Ia/IIa, and IIb/IIIa. Using radioimmunoprecipitation techniques, a protein was precipitated that migrated at 175 Kd (reduced). Under nonreduced conditions, a 150-Kd protein was detected with a minor component at 175Kd. The detection of the alloantigens was not activation-dependent. Using immunodepletion studies, we demonstrated that each alloantiserum recognized an epitope on a discrete population of the 175-Kd platelet protein. Family studies demonstrated that the alloantigens designated as Gova and Govb were inherited in an autosomal codominant fashion. The phenotypic frequencies were Gova/Gova, 26%; Gova/Govb, 55%; Govb/Govb, 19%; giving gene frequencies of 0.532 and 0.468 for Gova and Govb, respectively (n = 33).

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2346781

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  5 in total

1.  Laboratory investigation of immune thrombocytopenia.

Authors:  M Warner; J G Kelton
Journal:  J Clin Pathol       Date:  1997-01       Impact factor: 3.411

2.  Multimerin is found in the alpha-granules of resting platelets and is synthesized by a megakaryocytic cell line.

Authors:  C P Hayward; D F Bainton; J W Smith; P Horsewood; R H Stead; T J Podor; T E Warkentin; J G Kelton
Journal:  J Clin Invest       Date:  1993-06       Impact factor: 14.808

3.  Large-scale molecular analysis of a 34 Mb interval on chromosome 6q: major refinement of the RP25 interval.

Authors:  M M Abd El-Aziz; I Barragan; C O'Driscoll; S Borrego; L Abu-Safieh; J I Pieras; M F El-Ashry; E Prigmore; N Carter; G Antinolo; S S Bhattacharya
Journal:  Ann Hum Genet       Date:  2007-05-29       Impact factor: 1.670

4.  Detection of a soluble form of CD109 in serum of CD109 transgenic and tumor xenografted mice.

Authors:  Hiroki Sakakura; Yoshiki Murakumo; Shinji Mii; Sumitaka Hagiwara; Takuya Kato; Masato Asai; Akiyoshi Hoshino; Noriyuki Yamamoto; Sayaka Sobue; Masatoshi Ichihara; Minoru Ueda; Masahide Takahashi
Journal:  PLoS One       Date:  2014-01-06       Impact factor: 3.240

5.  Suppression of skin tumorigenesis in CD109-deficient mice.

Authors:  Masaki Sunagawa; Shinji Mii; Atsushi Enomoto; Takuya Kato; Yoshiki Murakumo; Yukihiro Shiraki; Naoya Asai; Masato Asai; Masato Nagino; Masahide Takahashi
Journal:  Oncotarget       Date:  2016-12-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.